A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

Researchers at Boston University have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) ...

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will ...

In testing 146 respiratory samples from a Boston safety-net hospital that were TB-negative according to conventional tests, ...

Agreement adds STR, SNP, microhaplotype and mitochondrial DNA MPS kits to Promega forensic product lineupMADISON, ...

Researchers at Boston University have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) in patients hospitalized ...

Leptomeningeal disease (LMD) remains one of the most challenging diagnoses in neuro-oncology. MRI returns normal or inconclusive results in 20 to 30 percent of confirmed cases, and CSF cytology can ...

The SRM Medical College Hospital and Research Centre (SRMMCHRC) has inaugurated a Genetic Clinic at its campus in suburban Kattankulathur.

Tempus AI, Inc. (TEM) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:45 AM EDTCompany ParticipantsJames Rogers - Chief ...

The Alberta government has introduced legislative changes that would allow people to pay out of pocket for medical testing ...

Myriad Genetics Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the use ...

Positive real-world head-to-head data on GraftAssureTM assay to be presented at the 39th European Immunogenetics and Histocompatibility Conference (EFI2026), April 21--24, 2026 in Edinburgh, Scotland ...